药品注册申请号:012828
申请类型:NDA (新药申请)
申请人:ABBOTT
申请人全名:ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 TRAVASE SUTILAINS OINTMENT;TOPICAL 82,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Yes No None 1969/06/12 Approved Prior to Jan 1, 1982 Discontinued
批准历史,通知信,药品说明书,综述等审批信息
批准日期申请类型申请提交号审查批准结论申请内容分类审评分类(优先审评;罕用药状态)通知信、综述、标签、说明书备注
1995/06/15 SUPPL 27 Approval Manufacturing (CMC) PRIORITY
1990/01/19 SUPPL 25 Approval Labeling PRIORITY
1990/01/19 SUPPL 24 Approval Manufacturing (CMC) PRIORITY
1988/01/11 SUPPL 23 Approval Manufacturing (CMC) PRIORITY
1986/07/24 SUPPL 22 Approval Manufacturing (CMC) PRIORITY
1982/03/22 SUPPL 21 Approval Manufacturing (CMC) PRIORITY
1981/06/20 SUPPL 20 Approval Labeling PRIORITY
1980/05/01 SUPPL 19 Approval Manufacturing (CMC) PRIORITY
1980/01/09 SUPPL 18 Approval Manufacturing (CMC) PRIORITY
1979/12/10 SUPPL 17 Approval Labeling PRIORITY
1979/10/16 SUPPL 16 Approval Manufacturing (CMC) PRIORITY
1978/10/26 SUPPL 15 Approval Manufacturing (CMC) PRIORITY
1978/10/26 SUPPL 14 Approval Manufacturing (CMC) PRIORITY
1974/08/09 SUPPL 9 Approval Supplement PRIORITY
1969/06/12 ORIG 1 Approval Type 1 - New Molecular Entity PRIORITY
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
本品无治疗等效药品
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2019 DrugFuture->U.S. FDA Drugs Database